Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman
06:11pm, Monday, 16'th Oct 2023
Evan Seigerman, BMO Capital Markets analyst, joins 'Closing Bell: Overtime' to discuss Pfizer and BioNTech cutting guidance amid Covid sales falling, the weight loss boom, and more.
Moderna Shares Slump Amid Concerns About COVID-19 Vaccine Demand
04:55pm, Monday, 16'th Oct 2023
Moderna (MRNA) was the worst-performing stock in the S&P 500 on Monday as shares lost over 6% after the biotech firm said it “remains comfortable” with its full-year guidance, but warned that it c
Moderna's stock slides to three-year low as co-founder sells more shares
02:55pm, Monday, 16'th Oct 2023
Shares of Moderna Inc. extended their slide Monday toward a fourth straight loss, a streak whose start coincided with a sale of shares by company co-founder and chair Noubar Afeyan.
Moderna Becomes Oversold
11:58am, Monday, 16'th Oct 2023
In trading on Monday, shares of Moderna entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $90.18 per share.
Moderna confirms COVID sales guidance as shares sink on Pfizer news
09:37am, Monday, 16'th Oct 2023
With its shares under pressure due to revised COVID guidance from Pfizer Inc. PFE, +3.38%, Moderna Inc. MRNA, -3.19% on Monday said it “remains comfortable” with its existing guidance on full-year
Moderna reaffirms annual COVID vaccine sales forecast
09:17am, Monday, 16'th Oct 2023
Moderna on Monday reaffirmed its forecast of $6 billion to $8 billion in COVID vaccine sales for the year, after rival Pfizer slashed forecast for its vaccine last week.
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
07:18am, Monday, 16'th Oct 2023
Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid.
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
06:10am, Monday, 16'th Oct 2023
Shares of Lululemon Athletica Inc. LULU, +1.00% rallied more than 5% after index provider S&P Dow Jones Indices said the stock will join the S&P 500 index SPX on Wednesday.
Don't Hold On: 7 Stocks to Sell Before 2024
09:30am, Sunday, 15'th Oct 2023
Even as the end of 2023 is still months away, now may be the time to figure out which stocks to sell ahead of 2024. All bets are off whether stocks can end the year on a high note.
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
06:00am, Friday, 13'th Oct 2023
The AI in healthcare market may be worth more than $190 billion by the end of this decade, making it a great place to look for investing opportunities. It's important to consider the whole picture whe
Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023
07:00am, Thursday, 12'th Oct 2023
CAMBRIDGE, MA / ACCESSWIRE / October 12, 2023 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 2, 2023 to report
3 Stocks That Are Down Big, But Are Due to Fall Much Further
06:30am, Thursday, 12'th Oct 2023
October is renowned for its potential to unsettle investors with significant market drops, a trend that continues from the previous month. Indeed, while certain stocks have shown an ability to weather
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
08:19pm, Wednesday, 11'th Oct 2023
In the closing of the recent trading day, Moderna (MRNA) stood at $102.76, denoting a -1.6% change from the preceding trading day.
3 Shaky Stocks to Sell in October Before It's Too Late
04:40pm, Monday, 09'th Oct 2023
Uncertainty abounds in the market right now. Whether driven by fears tied to surging inflation, rising interest rates, or geopolitical turmoil, investors have plenty to consider moving forward.
Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
08:00am, Saturday, 07'th Oct 2023
Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about that delay.
